AP3 Biomedical is a company that develops advanced tests for prostate cancer. It hired Paperbirch Strategies to lobby Congress and federal officials about health issues, specifically educating lawmakers about innovations in prostate cancer screening. The filings show three lobbying reports totaling $60,000 through January 20, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DARREN WILLCOX
The latest disclosures for this client.
W STRATEGIES, LLC
Q2W STRATEGIES, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
W STRATEGIES, LLC
W STRATEGIES, LLC
Q4W STRATEGIES, LLC
Q3W STRATEGIES, LLC
RR